Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas
Simplifying T2D therapy, when suitable and without compromising treatment efficacy and safety, offers the opportunity to ease disease burden.
The manufacturing process of aP vaccines consists in eliminating the endotoxins, resulting in a vaccine that is well tolerated.1